Gastrointestinal malignancies remain leading causes of cancer mortality, yet their sensitivity to immunotherapy differs sharply across anatomical sites, histologies, molecular subtypes, and disease stages. Immune checkpoint blockade has established durable clinical benefit in microsatellite instability-high colorectal...
Bo Liu, Lei Wang, Yue-Han Ma et al.· Frontiers in Immunology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.